ASP Isotopes Sees Unusually High Options Volume (NASDAQ:ASPI)

Key Points

• ASP Isotopes Inc. (NASDAQ:ASPI) experienced a dramatic increase in options trading, with 28,640 call options traded, marking a 342% rise compared to its average daily volume.
• The stock has seen a 1.4% decrease in trading, closing at $11.05, while institutional investors have been actively buying, with several firms increasing their holdings significantly.
• Analysts from Canaccord Genuity Group raised their price target for ASP Isotopes from $8.50 to $11.00, indicating a bullish outlook on the stock.

ASP Isotopes Inc. (NASDAQ:ASPI - Get Free Report) saw unusually large options trading activity on Wednesday. Investors acquired 28,640 call options on the company. Thisisanincreaseof342% compared to the average daily volume of 6,475 call options.

ASP Isotopes Trading Down 1.4%

NASDAQ ASPI traded down $0.16 during trading on Wednesday, reaching $11.05. 3,962,946 shares of the stock traded hands, compared to its average volume of 2,994,967. The firm has a market cap of $927.43 million, a price-to-earnings ratio of -18.08 and a beta of 3.36. The stock's 50-day moving average price is $8.55 and its 200 day moving average price is $6.56. The company has a quick ratio of 7.17, a current ratio of 7.21 and a debt-to-equity ratio of 0.80. ASP Isotopes has a fifty-two week low of $1.95 and a fifty-two week high of $11.68.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. BNP Paribas Financial Markets acquired a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $34,000. Ameritas Investment Partners Inc. boosted its holdings in shares of ASP Isotopes by 41.2% in the second quarter. Ameritas Investment Partners Inc. now owns 5,483 shares of the company's stock valued at $40,000 after buying an additional 1,600 shares during the period. SBI Securities Co. Ltd. boosted its holdings in shares of ASP Isotopes by 84.8% in the first quarter. SBI Securities Co. Ltd. now owns 9,370 shares of the company's stock valued at $44,000 after buying an additional 4,299 shares during the period. Russell Investments Group Ltd. boosted its holdings in shares of ASP Isotopes by 56.3% in the fourth quarter. Russell Investments Group Ltd. now owns 10,221 shares of the company's stock valued at $46,000 after buying an additional 3,682 shares during the period. Finally, Covestor Ltd acquired a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $54,000. Institutional investors and hedge funds own 16.80% of the company's stock.

Analysts Set New Price Targets

Separately, Canaccord Genuity Group lifted their price target on shares of ASP Isotopes from $8.50 to $11.00 and gave the stock a "buy" rating in a research report on Wednesday, May 21st.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.